Armor Investment Advisors’s iShares US Medical Devices ETF IHI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $840K | Sell |
15,750
-1,497
| -9% | -$87.9K | 0.3% | 55 |
|
|
2025
Q4 | $1.07M | Sell |
17,247
-3,063
| -15% | -$189K | 0.39% | 45 |
|
|
2025
Q3 | $1.22M | Sell |
20,310
-18,598
| -48% | -$1.14M | 0.39% | 50 |
|
|
2025
Q2 | $2.44M | Sell |
38,908
-981
| -2% | -$59K | 0.92% | 28 |
|
|
2025
Q1 | $2.4M | Buy |
39,889
+44
| +0.1% | +$2.73K | 0.99% | 25 |
|
|
2024
Q4 | $2.32M | Buy |
39,845
+631
| +2% | +$37.5K | 0.96% | 25 |
|
|
2024
Q3 | $2.32M | Buy |
39,214
+1,078
| +3% | +$61.6K | 0.96% | 26 |
|
|
2024
Q2 | $2.14M | Buy |
38,136
+279
| +0.7% | +$15.6K | 0.99% | 27 |
|
|
2024
Q1 | $2.22M | Sell |
37,857
-343
| -0.9% | -$19.4K | 1.07% | 27 |
|
|
2023
Q4 | $2.06M | Buy |
38,200
+1,116
| +3% | +$54.5K | 1.09% | 29 |
|
|
2023
Q3 | $1.8M | Buy |
37,084
+268
| +0.7% | +$14.2K | 1.07% | 29 |
|
|
2023
Q2 | $2.08M | Sell |
36,816
-972
| -3% | -$53.5K | 1.26% | 26 |
|
|
2023
Q1 | $2.04M | Buy |
37,788
+18
| +0% | +$958 | 1.17% | 27 |
|
|
2022
Q4 | $1.99M | Buy |
37,770
+638
| +2% | +$32.4K | 1.21% | 25 |
|
|
2022
Q3 | $1.75M | Buy |
37,132
+72
| +0.2% | +$3.74K | 1.19% | 28 |
|
|
2022
Q2 | $1.87M | Buy |
37,060
+695
| +2% | +$37.9K | 1.21% | 28 |
|
|
2022
Q1 | $2.22M | Buy |
36,365
+961
| +3% | +$57.3K | 1.25% | 25 |
|
|
2021
Q4 | $2.33M | Sell |
35,404
-466
| -1% | -$29.8K | 1.31% | 22 |
|
|
2021
Q3 | $2.25M | Sell |
35,870
-664
| -2% | -$42.4K | 1.41% | 20 |
|
|
2021
Q2 | $2.2M | Buy |
36,534
+102
| +0.3% | +$5.9K | 1.33% | 25 |
|
|
2021
Q1 | $2.01M | Sell |
36,432
-132
| -0.4% | -$7.32K | 1.3% | 25 |
|
|
2020
Q4 | $1.99M | Buy |
36,564
+6,714
| +22% | +$351K | 1.41% | 19 |
|
|
2020
Q3 | $1.49M | Sell |
29,850
-3,942
| -12% | -$191K | 1.28% | 28 |
|
|
2020
Q2 | $1.49M | Sell |
33,792
-414
| -1% | -$17.7K | 1.29% | 27 |
|
|
2020
Q1 | $1.28M | Sell |
34,206
-2,148
| -6% | -$90.4K | 1.31% | 25 |
|
|
2019
Q4 | $1.6M | Buy |
36,354
+516
| +1% | +$21.7K | 1.24% | 26 |
|
|
2019
Q3 | $1.48M | Buy |
35,838
+1,926
| +6% | +$78.8K | 1.21% | 27 |
|
|
2019
Q2 | $1.36M | Buy |
33,912
+966
| +3% | +$36.6K | 1.15% | 27 |
|
|
2019
Q1 | $1.27M | Buy |
32,946
+5,046
| +18% | +$183K | 1.1% | 30 |
|
|
2018
Q4 | $929K | Buy |
27,900
+1,920
| +7% | +$66.5K | 0.94% | 35 |
|
|
2018
Q3 | $985K | Buy |
25,980
+3,600
| +16% | +$128K | 0.88% | 36 |
|
|
2018
Q2 | $748K | Buy |
22,380
+13,380
| +149% | +$436K | 0.67% | 50 |
|
|
2018
Q1 | $278K | Buy |
9,000
+6,060
| +206% | +$187K | 0.25% | 81 |
|
|
2017
Q4 | $85K | Buy |
+2,940
| New | +$84.8K | 0.08% | 108 |
|
Other funds holding IHI
Armor Investment Advisors's IHI Position: Q1 2026 in Review
Armor Investment Advisors reduced its iShares US Medical Devices ETF (IHI) stake by 8.7% in Q1 2026, selling an estimated $87.9K and leaving 15,750 shares worth $840K. The position accounts for 0.3% of the portfolio, ranked #55.
Armor Investment Advisors first reported a position in IHI in Q4 2017 and has held it in 34 quarters since. The position peaked at $2.44M in Q2 2025. 504 funds tracked by Wall St. Rank hold IHI as of Q1 2026.
- Armor Investment Advisors held 15,750 shares of iShares US Medical Devices ETF worth $840K as of Q1 2026.
- Armor Investment Advisors sold 1,497 iShares US Medical Devices ETF shares in Q1 2026, an estimated $87.9K.
- iShares US Medical Devices ETF made up 0.3% of Armor Investment Advisors's portfolio in Q1 2026, its #55 holding.
- Armor Investment Advisors first reported a position in iShares US Medical Devices ETF in Q4 2017 and has held it in 34 quarters since.
- Armor Investment Advisors's iShares US Medical Devices ETF position peaked at $2.44M in Q2 2025.
- 504 funds tracked by Wall St. Rank held iShares US Medical Devices ETF as of Q1 2026.
Based on Armor Investment Advisors's 13F filing for Q1 2026, filed 29 Apr 2026.